Logos Global Management LP Akero Therapeutics, Inc. Transaction History
Logos Global Management LP
- $1.07 Billion
- Q2 2024
A detailed history of Logos Global Management LP transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Logos Global Management LP holds 800,000 shares of AKRO stock, worth $26.4 Million. This represents 1.76% of its overall portfolio holdings.
Number of Shares
800,000
Previous 800,000
-0.0%
Holding current value
$26.4 Million
Previous $18.8 Million
-0.0%
% of portfolio
1.76%
Previous 1.76%
Shares
4 transactions
Others Institutions Holding AKRO
# of Institutions
176Shares Held
72MCall Options Held
178KPut Options Held
164K-
Janus Henderson Group PLC London, X06.88MShares$227 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$185 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.43MShares$179 Million2.13% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$173 Million4.29% of portfolio
-
Wellington Management Group LLP Boston, MA5.11MShares$169 Million0.02% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $1.53B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...